De Carolis Lanfranco, Galli Silvia, Bianchini Edoardo, Rinaldi Domiziana, Raju Manikandan, Caliò Bianca, Alborghetti Marika, Pontieri Francesco E
Neurology Unit, NESMOS Department, Faculty of Medicine & Psychology, Sapienza-University of Rome, Sant'Andrea University Hospital, 00189 Rome, Italy.
Department of Clinical and Behavioral Neurology, IRCCS-Fondazione Santa Lucia, 00179 Rome, Italy.
Brain Sci. 2023 Jan 17;13(2):157. doi: 10.3390/brainsci13020157.
The interactions between the age at onset with other pathogenic mechanisms and the interplays between the disease progression and the aging processes in Parkinson's disease (PD) remain undefined, particularly during the first years of illness. Here, we retrospectively investigated the clinical presentation and evolution of the motor and non-motor symptoms and treatment-related complications during the first 5 years of illness in subjects categorized according to age at onset. A total of 131 subjects were divided into "Early-Onset-PD" (EOPD; onset ≤49 years), "Middle-Onset-PD" (MOPD; onset 50-69 years) and "Late-Onset-PD" (LOPD; onset ≥70 years). The T0 visit was set at the time of the clinical diagnosis; the T1 visit was 5 years (±5 months) later. At T0, there were no significant differences in the motor features among the groups. At T1, the LOPD patients displayed a significantly higher frequency of gait disturbances and a higher frequency of postural instability. Moreover, at T1, the LOPD subjects reported a significantly higher frequency of non-motor symptoms; in particular, cardiovascular, cognitive and neuropsychiatric domains. The presented results showed a significantly different progression of motor and non-motor symptoms in the early course of PD according to the age at onset. These findings contribute to the definition of the role of age at onset on disease progression and may be useful for the pharmacological and non-pharmacological management of PD.
帕金森病(PD)发病年龄与其他致病机制之间的相互作用,以及疾病进展与衰老过程之间的相互影响仍不明确,尤其是在疾病的最初几年。在此,我们回顾性研究了根据发病年龄分类的受试者在疾病最初5年中运动和非运动症状的临床表现及演变,以及与治疗相关的并发症。总共131名受试者被分为“早发型帕金森病”(EOPD;发病年龄≤49岁)、“中发型帕金森病”(MOPD;发病年龄50 - 69岁)和“晚发型帕金森病”(LOPD;发病年龄≥70岁)。T0访视设定在临床诊断时;T1访视在5年后(±5个月)。在T0时,各组之间的运动特征没有显著差异。在T1时,LOPD患者步态障碍的发生率显著更高,姿势不稳的发生率也更高。此外,在T1时,LOPD受试者报告的非运动症状发生率显著更高;特别是在心血管、认知和神经精神领域。呈现的结果表明,根据发病年龄,PD早期运动和非运动症状的进展存在显著差异。这些发现有助于明确发病年龄在疾病进展中的作用,可能对PD的药物和非药物管理有用。